Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Antibiotics vs Oral Suppression for Recurrent UTI in Post-menopausal Women
NCT04285320Phase 4Unknown
- Sponsor
- Atlantic Health System
- Start
- Mar 2021
- Primary completion
- Apr 2023
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
01
Overview
A Phase 4 trial of amikacin, gentamicin, tobramycin in urinary tract infection (UTI), sponsored by Atlantic Health System. Status: unknown.
02
Drugs
amikacingentamicintobramycin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT04285320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04285320.